ETF Managers Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$94.8K Buy
+27,396
New +$133K ﹤0.01% 636
2022
Q4
Sell
-24,522
Closed -$98K 601
2022
Q3
$98K Sell
24,522
-1,589
-6% -$12.1K ﹤0.01% 652
2022
Q2
$284K Buy
26,111
+1,867
+8% +$22.4K 0.01% 609
2022
Q1
$459K Buy
24,244
+648
+3% +$16.6K 0.01% 485
2021
Q4
$1.13M Sell
23,596
-2,889
-11% -$173K 0.02% 262
2021
Q3
$1.89M Buy
26,485
+4,286
+19% +$310K 0.04% 209
2021
Q2
$1.79M Buy
22,199
+159
+0.7% +$10.5K 0.03% 230
2021
Q1
$1.04M Sell
22,040
-12,249
-36% -$665K 0.02% 267
2020
Q4
$1.45M Buy
34,289
+1,882
+6% +$74.1K 0.03% 216
2020
Q3
$1.24M Buy
32,407
+16,432
+103% +$542K 0.04% 186
2020
Q2
$458K Buy
+15,975
New +$330K 0.02% 279

Other funds holding NBP

ETF Managers Group's NBP Position: Q1 2023 in Review

ETF Managers Group opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023: 27,396 shares worth $94.8K. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in NBP as recently as Q3 2022.

ETF Managers Group first reported a position in NBP in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.89M in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

  • ETF Managers Group held 27,396 shares of NovaBridge Biosciences American Depositary Shares worth $94.8K as of Q1 2023.
  • NovaBridge Biosciences American Depositary Shares was a new ETF Managers Group position in Q1 2023.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #636 holding.
  • ETF Managers Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 11 quarters since.
  • ETF Managers Group's NovaBridge Biosciences American Depositary Shares position peaked at $1.89M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.